Corbus Pharmaceuticals I... (CRBP)
NASDAQ: CRBP
· Real-Time Price · USD
9.25
-0.38 (-3.95%)
At close: Aug 15, 2025, 3:59 PM
9.43
1.95%
After-hours: Aug 15, 2025, 04:56 PM EDT
Corbus Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 1.35M | 1.35M | 1.35M | 1.35M | n/a | n/a | n/a | n/a | -881.71K | -784.38K | -647.82K | n/a | 1.54M | 2.67M | 2.82M |
Cost of Revenue | 146K | 346K | 497.69K | 499.67K | 652.48K | 610.82K | 459.13K | 685.37K | 907.36K | 1.12M | 1.49M | 1.35M | 9.29M | 20.18M | 30.54M | 46.41M | 65.62M | 85.04M |
Gross Profit | n/a | -200K | -351.69K | 850.12K | 697.31K | 738.97K | 890.65K | -685.37K | -907.36K | -1.12M | -1.49M | -2.23M | -10.07M | -20.83M | -30.54M | -44.87M | -62.95M | -82.22M |
Operating Income | -67.04M | -58.87M | -48.72M | -46.22M | -40.2M | -37.4M | -45.08M | -45.77M | -44.46M | -48.62M | -39.84M | -39.04M | -44.73M | -49.09M | -55.99M | -66.8M | -86.9M | -108.34M |
Interest Income | 7.74M | 7.33M | 5.65M | 2.1M | 906.76K | 232.76K | 232.76K | 233.4K | 233.18K | 1.18K | 1.18K | 541.89 | n/a | n/a | n/a | 679.71K | 679.71K | 692.35K |
Pretax Income | -57.95M | -50.29M | -40.21M | -38.7M | -34.97M | -33.76M | -44.6M | -47.46M | -46.19M | -50.65M | -42.35M | -41.73M | -35.12M | -39.01M | -45.64M | -43.99M | -76.71M | -97.68M |
Net Income | -57.95M | -50.29M | -40.21M | -38.7M | -34.97M | -33.76M | -44.6M | -47.53M | -46.45M | -62.52M | -55.86M | -55.18M | -48.38M | -40.66M | -45.64M | -43.99M | -76.71M | -97.68M |
Selling & General & Admin | 16.61M | 16.57M | 16.15M | 15.3M | 13.55M | 13.56M | 13.76M | 15.34M | 16.48M | 17.38M | 18.7M | 18.38M | 19.58M | 20.32M | 20.43M | 21.55M | 23.96M | 26.12M |
Research & Development | 50.42M | 42.1M | 32.22M | 30.41M | 26.16M | 23.54M | 31.17M | 30.43M | 27.99M | 26.24M | 16.14M | 15.66M | 20.25M | 29.01M | 36.45M | 46.79M | 65.62M | 85.04M |
Other Expenses | n/a | n/a | n/a | n/a | 217.54K | 400.2K | 400.2K | 675.75K | 535.92K | 144.58K | -48.77K | -214.66K | 11.74M | 11.72M | 11.9M | 25.06M | 13.02M | 13.25M |
Operating Expenses | 66.89M | 58.53M | 48.22M | 45.72M | 39.7M | 37.1M | 44.93M | 45.77M | 44.46M | 43.62M | 34.84M | 34.04M | 39.83M | 49.33M | 56.87M | 68.34M | 89.57M | 111.16M |
Interest Expense | 381K | 1.03M | 1.21M | 1.92M | 2.3M | 2.66M | 2.48M | 2.41M | 2.19M | 1.67M | 2.13M | 1.88M | 1.73M | 1.64M | 1.83M | 1.44M | 1.5M | 1.1M |
Selling & Marketing Expenses | n/a | -200K | -351.69K | -499.67K | -499.67K | -299.67K | -147.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 47.88M | 58.87M | 48.72M | 46.22M | 40.2M | 37.4M | 45.08M | 45.77M | 44.46M | 43.62M | 34.84M | 34.04M | 39.83M | 49.33M | 56.87M | 68.34M | 89.57M | 111.16M |
Income Tax Expense | n/a | n/a | 2.00 | 2.00 | 2.00 | 2.00 | n/a | 65.8K | 260.26K | 11.87M | 13.52M | 13.45M | 13.26M | 1.65M | n/a | 635.94K | 635.94K | 635.94K |
Shares Outstanding (Basic) | 12.24M | 12.2M | 12.18M | 12.01M | 2.81M | 2.81M | 4.42M | 4.42M | 4.28M | 4.18M | 4.17M | 4.17M | 4.17M | 4.17M | 4.17M | 4.17M | 3.88M | 3.88M |
Shares Outstanding (Diluted) | 12.24M | 12.2M | 12.18M | 12.01M | 2.81M | 2.81M | 4.42M | 4.42M | 4.28M | 4.18M | 4.17M | 4.18M | 4.18M | 4.17M | 4.17M | 4.17M | 3.88M | 3.88M |
EPS (Basic) | -4.76 | -6.87 | -7.93 | -8.96 | -10.08 | -8.58 | -10.37 | -11.18 | -11.06 | -14.97 | -13.39 | -13.23 | -11.6 | -10.06 | -11.54 | -12.04 | -24.31 | -35.36 |
EPS (Diluted) | -4.76 | -6.87 | -7.93 | -8.96 | -10.08 | -8.58 | -10.37 | -11.18 | -11.06 | -14.96 | -13.38 | -13.22 | -11.59 | -10.06 | -11.54 | -12.04 | -24.31 | -35.36 |
EBITDA | -39.53M | -48.68M | -41.25M | -41.82M | -37.71M | -36.59M | -44.24M | -44.9M | -43.75M | -42.87M | -34.07M | -32.95M | -37.98M | -47.15M | -53.82M | -64.85M | -85.61M | -106.97M |
EBIT | -39.91M | -49.26M | -41.9M | -43.08M | -38.97M | -37.81M | -45.49M | -45.57M | -44.52M | -43.67M | -34.89M | -34.1M | -39.73M | -49.09M | -55.99M | -66.8M | -86.9M | -108.34M |
Depreciation & Amortization | 298K | 498K | 649.69K | 651.67K | 652.48K | 610.82K | 641K | 867.24K | 1.09M | 1.3M | 1.49M | 1.49M | 1.53M | 1.58M | 1.64M | 1.69M | 1.62M | 1.66M |